EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial release from a lipid bilayer titanium implant coating is triggered by Staphylococcus aureus alpha-haemolysin

Liana Azizova, Adnan Al Dalaty, Emmanuel Brousseau, James Birchall, Thomas Wilkinson, Alastair Sloan, Wayne Nishio Ayre

Applied Surface Science · 2024-08 · 665 · 160337

DOI: 10.1016/j.apsusc.2024.160337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Surface Science, 2024-08. Verfasst von Liana Azizova und 6 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infections represent a significant challenge in joint replacements, often leading to the need for high-risk revision surgeries. There is an unmet need for novel technologies that are triggered by pathogens to prevent long-term joint replacement infections. The use of supported lipid bilayers (SLBs) with encapsulated antimicrobial agents, which are responsive to bacterial virulence factors, offers an exciting approach to achieving this goal. In this study, Ti was functionalised using octadecylphosphonic acid (ODPA) to form an SLB with encapsulated antibiotic (novobiocin) effective against methicillin-resistant Staphylococcus aureus. Using the solvent-assisted method, the SLB with encapsulated novobiocin was developed on the surface of ODPA-modified Ti quartz crystal microbalance (QCM) sensors. QCM monitoring and fluorescence microscopy supported the successful formation of a planar SLB with encapsulated novobiocin. Incorporation of novobiocin in the SLB resulted in significantly reduced attachment and viability of S. aureus NCTC 7791, with no significant reduction in human bone marrow stromal cell viability. Additionally, in the presence of varying concentrations of α-haemolysin, a virulence factor from S. aureus, the SLB demonstrates a dose-dependent release pattern. The findings indicate the possibility of creating a biocompatible implant coating that releases an antimicrobial in the presence of a bacterial virulence factor, in a dose-dependent manner.

Förderung

  • Engineering and Physical Sciences Research Council

Zitieren

APA

Azizova, L., Dalaty, A. A., Brousseau, E., Birchall, J., Wilkinson, T., Sloan, A., & Ayre, W. N. (2024). Antimicrobial release from a lipid bilayer titanium implant coating is triggered by Staphylococcus aureus alpha-haemolysin. Applied Surface Science, 665, 160337. https://doi.org/10.1016/j.apsusc.2024.160337

Vancouver

Azizova L, Dalaty AA, Brousseau E, Birchall J, Wilkinson T, Sloan A, et al. Antimicrobial release from a lipid bilayer titanium implant coating is triggered by Staphylococcus aureus alpha-haemolysin. Applied Surface Science. 2024;665:160337. doi:10.1016/j.apsusc.2024.160337

BibTeX
@article{Azizova2024,
  author = {Azizova, Liana and Dalaty, Adnan Al and Brousseau, Emmanuel and Birchall, James and Wilkinson, Thomas and Sloan, Alastair and Ayre, Wayne Nishio},
  title = {Antimicrobial release from a lipid bilayer titanium implant coating is triggered by Staphylococcus aureus alpha-haemolysin},
  journal = {Applied Surface Science},
  year = {2024},
  volume = {665},
  pages = {160337},
  doi = {10.1016/j.apsusc.2024.160337}
}
Kostenlos starten →